Antiretroviral therapy coverage for PMTCT in Laos
Laos: Antiretroviral therapy coverage for PMTCT was 68.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Laos, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage for pmtct in Laos is 68.0%, measured in 2024. That is the highest value across all 25 years on record.
The figure is up 38.8% on the previous year and up 518.2% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Laos peaked at 68.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Laos 54th out of 84 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Laos, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 12.0% | — |
| 2007 | 11.0% | -8.3% |
| 2008 | 9.0% | -18.2% |
| 2009 | 10.0% | +11.1% |
| 2010 | 10.0% | +0.0% |
| 2011 | 19.0% | +90.0% |
| 2012 | 18.0% | -5.3% |
| 2013 | 20.0% | +11.1% |
| 2014 | 11.0% | -45.0% |
| 2015 | 12.0% | +9.1% |
| 2016 | 28.0% | +133.3% |
| 2017 | 28.0% | +0.0% |
| 2018 | 32.0% | +14.3% |
| 2019 | 24.0% | -25.0% |
| 2020 | 28.0% | +16.7% |
| 2021 | 36.0% | +28.6% |
| 2022 | 43.0% | +19.4% |
| 2023 | 49.0% | +14.0% |
| 2024 | 68.0% | +38.8% |
Laos compared with similar countries
- Laos's 68.0% is below the median for lower middle income countries, which is 83.5%, 81% of the median. (32 countries reporting)
- Laos's 68.0% is above the median for East Asia & Pacific, which is 68.0%, 1.0× the median. (9 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.2% | 0.0% | 12.0% | 10 |
| 2010s | 20.2% | 10.0% | 32.0% | 10 |
| 2020s | 44.8% | 28.0% | 68.0% | 5 |
Countries ranked near Laos
- 51 Libya 70.0% compare
- 52 Burkina Faso 69.0% compare
- 52 Central African Republic 69.0% compare
- 54 Dominican Republic 68.0% compare
- 56 El Salvador 66.0% compare
- 56 Suriname 66.0% compare
More health data for Laos
- Un projection of annual infant deaths, annual growth rate -2.76 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5667 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,260 deaths per 1,000 people (2090)
- Number of infants who die before age 1 317 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 15 (2025)
- Population ages 00-04, female, annual growth rate -0.5161 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0489 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5055 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Laos?
- Antiretroviral therapy coverage for pmtct in Laos was 68.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Laos?
- The highest recorded value was 68.0% in 2024.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Laos?
- The lowest recorded value was 0.0% in 2000.
- How does Laos rank for antiretroviral therapy coverage for pmtct?
- Laos ranks 54th out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Laos?
- Over the last ten years it is up 518.2%. The long-run trend across the full record is volatile.
- Where does this Laos data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).